SEARCH

SEARCH BY CITATION

References

  • 1
    Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51(Suppl. 1): 24 9.
  • 2
    Johnsson F, Joelsson B, Gudmundsson K, et al. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987; 22: 714 18.
  • 3
    Joelsson B & Johnsson F. Heartburn—the acid test. Gut 1989; 30: 1523 5.
  • 4
    Richter JE, Sabesin SM, Kogut DG, et al. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease. Am J Gastroenterol 1996; 91: 1766 72.
  • 5
    Quigley EMM. Gastroesophageal reflux disease: the roles of motility in pathophysiology and therapy. Am J Gastroenterol 1993; 88: 1649 51.
  • 6
    Sontag SJ, Schnell TG, Miller TQ, et al. The importance of hiatal hernia in reflux esophagitis compared with lower esophageal sphincter pressure or smoking. J Clin Gastroenterol 1991; 13: 628 43.
  • 7
    Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Dig Dis 1976; 21: 953 6.
  • 8
    Kahrilas PJ. Gastroesophageal reflux disease. J Am Med Assoc 1996; 276: 983 8.
  • 9
    Green JRB. Is there such an entity as mild oesophagitis? Eur J Clin Res 1993; 4: 29 34.
  • 10
    Johansson K-E, Ask P, Boeryd B, et al. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 837 47.
  • 11
    DeVault KR & Castell DO. Current diagnosis and treatment of gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 867 76.
  • 12
    DeVault KR & Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995; 155: 2165 73.
  • 13
    Sandmark S, Carlsson R, Fausa O, et al. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 625 32.
  • 14
    Howden CW. Appropriate acid suppression in the treatment of acid-related conditions. Pharmacol Ther 1994; 63: 123 34.
  • 15
    Bell NJV & Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992; 33: 118 24.
  • 16
    Bianchi Porro G, Pace F, Peracchia A, et al. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine. J Clin Gastroenterol 1992; 15: 192 8.
  • 17
    Meuwissen SGM & Klinkenberg-Knol EC. Management of gastro-oesophageal reflux disease. Digestion 1989; 44(Suppl. 1): 54 62.
  • 18
    Zeitoun P, Rampal P, Barbier P, et al. Oméprazole (20 mg/j) comparéà ranitidine (150 mg 2 fois/j) dans le traitement de l’oesophagite par reflux. Résultats d’un essai multicentrique franco-belge, randomisé en double insu. Gastroenterol Clin Biol 1989; 13: 457 62.
  • 19
    James OFW & Parry-Billings KS. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis. Age Ageing 1994; 23: 121 6.
  • 20
    Festen HPM, Tan TG, Snel P, et al. Symptom relief in symptomatic mild reflux oesophagitis: omeprazole 20 mg o.m. more effective than high dose ranitidine 300 mg b.i.d. Eur J Gastroenterol Hepatol 1996; 8: A34A34 (Abstract).
  • 21
    Hungin APS, Gunn SD, Bate CM, et al. A comparison of the efficacy of omeprazole 20 mg once daily with ranitidine 150 mg bd in the relief of symptomatic gastro-oesophageal reflux disease in general practice. Br J Clin Res 1993; 4: 73 88.
  • 22
    Venables T, Newland R, Patel AC, et al. A comparison of omeprazole 10 mg and 20 mg om with ranitidine 150 mg bd for the treatment of GORD in primary care. Gut 1995; 37(Suppl. 2): A45A45 (Abstract).
  • 23
    Zagari M, Villa KF, Freston JW. Proton pump inhibitors versus H2-receptor antagonists for the treatment of erosive gastroesophageal reflux disease: a cost-comparative study. Am J Man Care 1995; 1: 247 55.
  • 24
    Hillman AL, Bloom BS, Fendrick AM, et al. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Int Med 1992; 152: 1467 72.
  • 25
    Bloom BS. Cost and quality effects of treating erosive esophagitis. Pharmacoeconomics 1995; 8: 139 46.
  • 26
    Spechler SJ and the Department of Veteran Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. New Engl J Med 1992; 326: 786 92.
  • 27
    De Simone M & Cioffi U. Therapeutic options in the management of gastroesophageal reflux disease. Panminerva Med 1998; 40: 139 45.
  • 28
    Lundell L, Dalenbäck J, Janatuinen E, et al. Comprehensive 1-year cost analysis of open antireflux surgery in Nordic countries. Br J Surg 1998; 85: 1002 5.